The 8p gene Neuregulin 1, which is one of the glial growth factors expressed during neurodevelopment and in the adult CNS, has recently been identified as a susceptibility gene for schizophrenia by linkage and LD mapping studies in the Icelandic and Scottish population. In the present work, the authors provide independent statistical support for the previous findings that schizophrenia is associated with the 5 0 end of the Neuregulin 1 gene.
The 8p gene Neuregulin 1, which is one of the glial growth factors expressed during neurodevelopment and in the adult CNS, has recently been identified as a susceptibility gene for schizophrenia by linkage and LD mapping studies in the Icelandic and Scottish population. In the present work, the authors provide independent statistical support for the previous findings that schizophrenia is associated with the 5 0 end of the Neuregulin 1 gene.
HERV-W-related RNA detected in plasma from individuals with recent-onset schizophrenia or schizoaffective disorder H Karlsson, J Schröder, S Bachmann, C Bottmer, RH Yolken
The authors previously reported that certain patients, suffering from recent-onset schizophrenia or schizoaffective disorder, harbor differentially detectable levels of endogenous retroviral RNA in CSF when compared to healthy control individuals. Presently, the authors report that, in plasma, retroviral RNA is more prevalent among patients than healthy control individuals. Further studies aiming at identifying the role of retroviral transcripts in the etiopathogenesis of schizophrenia are warranted.
FEATURE REVIEW
The Molecular genetics of schizophrenia: new findings promise new insights MJ Owen, NM Williams, MC O'Donovan Individual differences in susceptibility to schizophrenia are very largely genetic. However, the lack of a simple one-to-one relationship between genotype and phenotype has made the task of identifying susceptibility genes difficult. Fortunately, there are now signs of real progress. Studies of genetic linkage and chromosomal abnormalities in schizophrenia have implicated a number of chromosomal regions. Recently, evidence implicating individual genes within some of the linked regions has been reported and more importantly replicated. These findings and their implications are reviewed. The potential association between estrogen receptor b (ERb) and disease was explored in a group of bulimic women. An association between two common polymorphisms in the ERb gene and disease was found in bulimic women compared to controls. More detailed characterization of the ERb gene identified a novel variant changing the primary structure of the ERb protein in one bulimic patient. These findings point towards a possible role of ERb and/or neighboring genes in the etiology of disease in bulimic patients.
Assessment of a prepulse inhibition deficit in a mutant mouse lacking mGluR5 receptors SA Brody, SC Dulawa, F Conquet, MA Geyer Abnormalities in the glutamate system appear to contribute to symptoms of schizophrenia, including a filtering mechanism measured by a cross-species paradigm known as prepulse inhibition of startle (PPI). The authors examined the role of a specific glutamate receptor, mGluR5, in PPI, using mice lacking the mGluR5 gene. As observed in persons with schizophrenia, PPI was disrupted dramatically in mice lacking mGluR5. These findings support the glutamate hypothesis of schizophrenia and identify a functional role for mGluR5 in sensorimotor gating.
ORIGINAL RESEARCH ARTICLES
Erythropoietin: a candidate compound for neuroprotection in schizophrenia H Ehrenreich, D Degner, J Meller, M Brines, M Be´he´, M Hasselblatt, H Woldt, P Falkai, F Knerlich, S Jacob, N von Ahsen, W Maier, W Brück, E Rüther, A Cerami, W Becker, A-L Sire´n Erythropoietin (EPO) is a candidate for neuroprotection in brain disease. The purpose of this study was to prepare the ground for a first neuroprotective add-on trial using EPO in schizophrenia to ameliorate cognition and arrest degeneration. The authors demonstrate that: (1) intravenous EPO reaches the brain; (2) EPO receptors are strongly expressed in brains of schizophrenic patients; (3) EPO prevents nerve cell death induced by antipsychotics; (4) EPO improves cognition in mice.
Modification of human 5-HT 2C receptor function by Cys23Ser, an abundant, naturally occurring aminoacid substitution M Okada, JK Northup, N Ozaki, JT Russell, M Linnoila, D Goldman A human serotonin 5-HT 2C receptor gene polymorphism leads to substitution of cysteine for serine at codon 23 (Cys23Ser). Cys23Ser has been reported to be associated with various mental disorders and drug response. Thus, in the present study, the authors assessed whether Cys23Ser could affect receptor function. Results indicated that Ser23 may be constitutively more active and desensitized easier than Cys23. Ser23 appears to be an abundant candidate allele, which could directly influence interindividual variation in behavior, susceptibility to mental disorder, and drug response.
Interleukin-1a (IL-1a) induced activation of p38 mitogen-activated protein kinase inhibits glucocorticoid receptor function X Wang, H Wu, AH Miller Previous studies have shown that the pro-inflammatory cytokine interleukin (IL)-1 can disrupt glucocorticoid receptor function, potentially contributing to impaired feedback regulation of neuroendocrine and immune responses in patients with neuropsychiatric and/or inflammatory disorders. This study demonstrates that IL-1 inhibits glucocorticoid receptor function in mouse fibroblasts by activating p38 mitogen-activated protein kinase (MAPK) signal transduction pathways. The data suggest that the p38 MAPK pathway may serve as a relevant therapeutic target to reverse impaired glucocorticoid receptor function in neuropsychiatric and/or inflammatory disorders.
Intestinal permeability is decreased in anorexia nervosa P Monteleone, R Carratù, M Cartenı´, M Generoso, M Lamberti, L De Magistris, F Brambilla, B Colurcio, M Secondulfo, M Maj Malnourished and fasting individuals have increased intestinal permeability (IP), suggesting an impaired barrier function of the intestinal mucosa. The authors hypothesized that IP was enhanced in women with anorexia nervosa, because of their chronic starvation and malnutrition. However, contrary to this hypothesis, the authors found a decreased IP in underweight anorexic women. This finding supports the occurrence of a potentiation of the barrier function of intestinal mucosa in malnourished anorexics, which may protect these emaciated individuals from the passage of potentially dangerous agents.
A genome-wide screen for genes influencing conduct disorder DM Dick, T-K Li, HJ Edenberg, V Hesselbrock, J Kramer, S Kuperman, B Porjesz, K Bucholz, A Goate, J Nurnberger Jr, T Foroud Genome-wide linkage analyses of retrospectively reported childhood conduct disorder and conduct disorder symptomatology were performed in the Collaborative Study on the Genetics of Alcoholism sample. The results suggest that regions on chromosomes 19 and 2 may contain genes conferring risk to conduct disorder. This study represents the first genome-wide screen directed toward identifying genes contributing to childhood conduct disorder.
Findings in an independent sample support an association between bipolar affective disorder and the G72/G30 locus on chromosome 13q33 Y-S Chen, N Akula, SD Detera-Wadleigh, TG Schulze, J Thomas, JB Potash, JR DePaulo, MG McInnis, NJ Cox, FJ McMahon Previous studies have implicated the genes G72 and G30, on chromosome 13q33, in both schizophrenia and bipolar disorder. In this issue, Chen et al show that the reported association between bipolar disorder and markers near these genes can be reproduced in an independent sample. The new findings involve different alleles than those reported previously, suggesting a complex relationship between disease and genetic variation at this locus. Further studies are needed to identify variants that alter function and modify disease risk.
Possible evidence for a common-risk locus for bipolar affective disorder and schizophrenia on chromosome 4p16 in patients from the Faroe Islands TD Als, HA Dahl, TJ Flint, AG Wang, M Vang, O Mors, TA Kruse, H Ewald
The present study supports the possibility that a locus on 4p16.1 may predispose to schizophrenia as well as bipolar affective disorder. In searching for a joint risk locus in a genetic isolate, a number of overlapping segments were supported by increased sharing among patients of one or more haplotypes. Chromosome 4p16 has also been implied in studies of patients collected from other neighboring and genetically related populations.
A mu-opioid receptor single nucleotide polymorphism in rhesus monkey: association with stress response and aggression GM Miller, J Bendor, S Tiefenbacher, H Yang, MA Novak, BK Madras
In humans, variations in the mu-opioid receptor gene are associated with differences in receptor affinity for b-endorphin and stress response. The authors discovered a single-nucleotide polymorphism in the rhesus monkey mu-opioid receptor-coding region (C77G) that is associated with increased affinity for b-endorphin, decreased cortisol levels, and increased aggressive threat behavior. The physiogenetic similarity between rhesus monkeys and humans supports the use of nonhuman primates to investigate the physiological and behavioral relevance of human muopioid receptor polymorphisms.
Serotonin-2A receptor gene locus does not contain common polymorphism affecting mRNA levels in adult brain NJ Bray, PR Buckland, H Hall, MJ Owen, MC O'Donovan
Relative expression of the 102T-and C-alleles of the HTR2A gene was measured in 23 genomic heterozygotes using mRNA derived from cerebral cortex. No difference was observed in the ratio of the two alleles compared with genomic DNA, indicating that they are equally expressed. A further absence of variability in allelic ratios between mRNA samples suggests that the HTR2A locus is unlikely to contain additional common polymorphisms or epigenetic modification that alter HTR2A mRNA levels in adult brain.
